• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).

出版信息

Genet Med. 2021 Nov;23(11):2027-2028. doi: 10.1038/s41436-021-01247-1. Epub 2021 Jun 28.

DOI:10.1038/s41436-021-01247-1
PMID:34183790
Abstract
摘要

相似文献

1
Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).针对多基因或多因素疾病的直接面向消费者的产前检测：美国医学遗传学与基因组学学会（ACMG）的立场声明
Genet Med. 2021 Nov;23(11):2027-2028. doi: 10.1038/s41436-021-01247-1. Epub 2021 Jun 28.
2
Correction to: Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).
Genet Med. 2021 Nov;23(11):2226. doi: 10.1038/s41436-021-01275-x.
3
The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).多基因风险评分的临床应用：美国医学遗传学与基因组学学会（ACMG）的一份要点声明
Genet Med. 2023 May;25(5):100803. doi: 10.1016/j.gim.2023.100803. Epub 2023 Mar 15.
4
Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).避免不公平歧视和基因信息滥用需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2022 Mar;24(3):512-520. doi: 10.1016/j.gim.2021.11.002. Epub 2021 Dec 16.
5
Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).疾病多基因风险评分发展的实验室视角：美国医学遗传学与基因组学学会（ACMG）的要点声明
Genet Med. 2023 May;25(5):100804. doi: 10.1016/j.gim.2023.100804. Epub 2023 Mar 27.
6
Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).多基因风险评分在胚胎选择中的临床应用：美国医学遗传学与基因组学学会（ACMG）的一份要点声明
Genet Med. 2024 Apr;26(4):101052. doi: 10.1016/j.gim.2023.101052. Epub 2024 Feb 23.
7
Response to "The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)".对《美国医学遗传学与基因组学学会（ACMG）关于将ACMG二级发现建议用于普通人群筛查的政策声明》的回应
Genet Med. 2019 Dec;21(12):2836-2837. doi: 10.1038/s41436-019-0572-4. Epub 2019 Jun 26.
8
Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics.直接面向消费者的基因检测：美国医学遗传学与基因组学学会的修订立场声明
Genet Med. 2016 Feb;18(2):207-8. doi: 10.1038/gim.2015.190. Epub 2015 Dec 17.
9
Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG).囊性纤维化跨膜传导调节因子（CFTR）携带者筛查的更新建议：美国医学遗传学与基因组学学会（ACMG）立场声明
Genet Med. 2023 Aug;25(8):100867. doi: 10.1016/j.gim.2023.100867. Epub 2023 Jun 13.
10
Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).单亲二体的诊断检测：美国医学遗传学与基因组学学会（ACMG）的一份要点声明
Genet Med. 2020 Jul;22(7):1133-1141. doi: 10.1038/s41436-020-0782-9. Epub 2020 Apr 16.

引用本文的文献

1
Are we nearly there yet? Starts and stops on the road to use of polygenic scores.我们快到了吗？多基因评分应用之路上的起起落落。
J Community Genet. 2023 Oct;14(5):439-440. doi: 10.1007/s12687-023-00672-w.
2
Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing.直接面向消费者环境下的多基因评分：消费者基因检测新时代的挑战与机遇
J Pers Med. 2023 Mar 23;13(4):573. doi: 10.3390/jpm13040573.